| # | (%) | [range] |
---|---|---|---|
Number of patients | 32 | Â | Â |
 Male | 14 | (40%) |  |
 Female | 19 | (60%) |  |
Median age on starting tamoxifen | 41 |  | [19–68] |
Site of origin | Â | Â | Â |
 Extremities (including girdle) | 18 | (56%) |  |
 Chest wall | 5 | (15%) |  |
 Pelvis | 3 | (10%) |  |
 Abdominal wall | 3 | (10%) |  |
 Paravertebral | 1 | (3%) |  |
 Head and neck | 2 | (6%) |  |
Sporadic disease | 31 | (97%) | Â |
FAP-associated | 1 | (3%) | Â |
Previous treatments | 18 | (56%) | Â |
 Local treatment | |||
  Surgery | 10 | (31%) |  |
  Surgery and RT | 7 | (21%) |  |
  RT alone | 0 |  |  |
 Systemic treatment | 4 | (12%) |  |
No previous treatment | 14 | (44%) | Â |